Description

Dose-response curves for curcumin and RuCurcumin inhibition of amyloid-beta aggregation, demonstrating the enhanced potency of the arene-ruthenium(II) derivative.

Figure 13

Chart

Source Paper

Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization.

International journal of molecular sciences (2022)

PMID: 35955845

DOI: 10.3390/ijms23158710

Cite This Figure

![Figure 13: Dose-response curves for curcumin and RuCurcumin inhibition of amyloid-beta aggregation, demonstrating the enhanced potency of the arene-ruthenium(II) derivative.]()

> Source: Massimiliano Cuccioloni et al. "Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthen." *International journal of molecular sciences*, 2022. PMID: [35955845](https://pubmed.ncbi.nlm.nih.gov/35955845/)

<figure>
  <img src="" alt="Dose-response curves for curcumin and RuCurcumin inhibition of amyloid-beta aggregation, demonstrating the enhanced potency of the arene-ruthenium(II) derivative." />
  <figcaption>Figure 13. Dose-response curves for curcumin and RuCurcumin inhibition of amyloid-beta aggregation, demonstrating the enhanced potency of the arene-ruthenium(II) derivative.<br>  Source: Massimiliano Cuccioloni et al. "Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthen." <em>International journal of molecular sciences</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35955845/">35955845</a></figcaption>
</figure>

Related Evidence

Curcumin for Age-Related Cognitive Decline

Grade B · 10 studies

Curcumin for Memory Loss

Grade C · 8 studies